CollPlant Biotechnologies Ltd. (CLGN)
3.51
-0.46
(-11.59%)
USD |
NASDAQ |
Oct 09, 16:00
3.61
+0.10
(+2.85%)
After-Hours: 20:00
CollPlant Biotechnologies EPS Diluted (Quarterly) : -1.890 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.890 |
| March 31, 2026 | -0.2253 |
| December 31, 2025 | -0.2505 |
| September 30, 2025 | -0.2738 |
| June 30, 2025 | -0.2827 |
| March 31, 2025 | -0.1268 |
| December 31, 2024 | -0.3386 |
| September 30, 2024 | -0.3777 |
| June 30, 2024 | -0.3675 |
| March 31, 2024 | -0.3663 |
| December 31, 2023 | -0.4094 |
| September 30, 2023 | -0.3825 |
| June 30, 2023 | 0.4892 |
| March 31, 2023 | -0.3296 |
| December 31, 2022 | -0.3934 |
| September 30, 2022 | -0.395 |
| June 30, 2022 | -0.3865 |
| March 31, 2022 | -0.358 |
| December 31, 2021 | -0.3502 |
| September 30, 2021 | -0.293 |
| June 30, 2021 | -0.2978 |
| March 31, 2021 | 0.88 |
| December 31, 2020 | -0.4202 |
| September 30, 2020 | 0.07 |
| June 30, 2020 | -0.2833 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -6.815 |
| June 30, 2019 | -2.677 |
| March 31, 2019 | -0.0087 |
| December 31, 2018 | 0.0044 |
| September 30, 2018 | -0.0058 |
| June 30, 2018 | -0.0072 |
| March 31, 2018 | -0.0123 |
| December 31, 2017 | -0.0114 |
| September 30, 2017 | -0.0084 |
| June 30, 2017 | -0.0111 |
| March 31, 2017 | -0.1073 |
| December 31, 2016 | -0.0183 |
| September 30, 2016 | -0.0473 |
| June 30, 2016 | -0.0157 |
| March 31, 2016 | -0.023 |
| December 31, 2015 | -0.0077 |
| September 30, 2015 | -0.0156 |
| June 30, 2015 | -0.0155 |
| March 31, 2015 | -0.0076 |
| December 31, 2014 | -0.0078 |
| September 30, 2014 | -0.0085 |
| June 30, 2014 | -0.0087 |
| March 31, 2014 | -0.0172 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.1004 |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.726M |
| Revenue (Quarterly) | 0.108M |
| Total Expenses (Quarterly) | 2.834M |
| Enterprise Value | 4.779M |
| Gross Profit Margin (Quarterly) | -604.6% |
| Profit Margin (Quarterly) | -2.52K% |
| Earnings Yield | -75.19% |
| Normalized Earnings Yield | -75.19 |